View the On-WebinarSubmitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready?
Webinar | Achieving Balance in Clinical Trial Database Design: Considerations for Enhancing Clinical Trial Efficiency
November 14, 2019
Designing a clinical trial database is a balancing act. Any clinical program has multiple stakeholders who have both short-term and long-term goals to achieve. A good database designer must understand the needs and goals of the sponsor and its various functional project team members. The designer must consider the ease of use for the clinical trial sites who will be entering the trial data, with the needs of the downstream stakeholders in biostatistics, programming, and medical writing. Additionally, we not only need to consider today’s priorities, we also must understand the overall strategy of the clinical program, especially as it moves forward past the current stage.
October 24, 2019
Veristat will be attending Clinical Trials Europe 2019, the conference formerly known as the Partnerships in Clinical Trial Europe conference, for the first time this year.
October 8, 2019
Join Veristat at AMWA 2019 Medical Writing & Communication Conference to learn about the trends and opportunities in the field of medical writing and medical communications.
Webinar SummaryPatient recruitment continues to be the number one reason for study delays. It is estimated for every day a drug is not on the market, $1 million USD is lost in revenue, and more importantly, patients suffering from illnesses are left waiting for products that can help them achieve their health goals or provide a better quality of life.
August 29, 2019
Veristat is excited to be heading to the Evolution Summit Fall 2019 taking place on Sept 11-13, 2019 in San Diego, CA. We will be co-hosting a Master Class session on Successful Sponsor/CRO Partnerships.
Webinar SummaryAccelerating the development of therapeutic products intended to treat serious conditions has been an interest of the public, legislators, and the scientific community for many years.
August 2, 2019
As of December 2016, the International Council for Harmonisation (ICH) adopted the revised E6 guideline, entitled “Integrated Addendum to Good Clinical Practice (GCP).” The new regulations within E6(R2) require the Sponsor to manage their study using a risk-based approach.
June 5, 2019
Meet Veristat at booth #1713 at the upcoming DIA Annual Meeting.